Syncom Formulations India Limited announced its financial results for the fiscal year ending March 2026. The company reported a revenue of INR 48,657,300 and a net profit of INR 7,600,800. The board approved these results with no audit modifications, and the EPS has been restated according to Ind AS 33 guidelines.

Syncom Formulations reported a significant 42% year-over-year increase in their Q4 net profit, reaching 251M. However, their quarterly revenue experienced a slight dip, dropping from 1.5B to 1.35B compared to the same period last year.

Syncom Formulations India Ltd has scheduled a board meeting for May 22, 2026, where they plan to review and approve their Q4 and full-year 2026 audited financial results. Investors await the outcome for insights into the company's performance over the period.

Syncom Formulations has purchased HDFC Bank's office on the 7th floor of Trade Star, Mumbai, for approximately INR 57.3 crore. This significant acquisition expands Syncom's presence in the city.